03/09/2026
Unlike one-size-fits-all treatments, these vaccines are designed specifically to train an individual patient’s immune system to recognise and fight their unique form of cancer, aiming to prevent it from returning.
Dana-Farber investigators, including Drs. Catherine Wu and Patrick Ott, are leading the way by continually refining these vaccines and testing them in clinical trials for cancers like melanoma and kidney cancer.
Read more about how this research is advancing precision medicine on blog.dana-farber.org/